Increased METTL3 in leukemic cells is required for the maintenance of differentiation arrest of AML cells by enhancing transcripts of c-MYC, BCL-2 and PTEN and inactivating the PI3K/AKT pathway, accompanied by elevated m6A abundance. Here, METTL3 is linked to acute myeloid leukemia.